Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men
- 7 December 2016
- journal article
- Published by Portico in BoneKEy Reports
- Vol. 5, 852
- https://doi.org/10.1038/bonekey.2016.85
Abstract
Hyperparathyroidism may be associated with skeletal and cardiovascular abnormalities, but it is unclear whether these associations exist for high-normal levels of parathyroid hormone (PTH). We assessed relationships between PTH and anthropometric, skeletal and cardiometabolic indices in normal men. Body composition, blood pressure, biochemistry and bone mineral density (BMD) were evaluated in 151 healthy men. BMD was reassessed at 2 years, and coronary artery calcium (CAC) was measured at 3.5 years. Relationships between PTH and other baseline characteristics, CAC scores and change in BMD were evaluated. PTH correlated positively with baseline body mass index, fat mass, diastolic blood pressure, triglycerides, total and low-density lipoprotein (LDL) cholesterol, (r=0.19-0.25, P=0.02-0.002), and with category of CAC score. Relationships between PTH and cardiometabolic indices remained significant after adjustment for age, 25-hydroxyvitamin D and estimated glomerular filteration rate. Men in the top PTH tertile (⩾4.4 pmol l-1, n=51) were more likely to have LDL cholesterol ⩾3.5 mmol l-1, diastolic blood pressure ⩾85 mm Hg, and CAC score >0 than men in lower tertiles. PTH was not associated with history of fracture, baseline BMD, or change in BMD over 2 years. In summary, in this cohort of healthy men, PTH levels are linearly related to adiposity and to cardiometabolic indices, but not to BMD or bone loss. These findings suggest that adiposity should be considered as an independent cause of secondary hyperparathyroidism, and they may be relevant to patients with normocalcemic hyperparathyroidism, in whom high PTH levels may be a marker of adiposity and cardiometabolic risk rather than always indicating parathyroid autonomy.Keywords
This publication has 45 references indexed in Scilit:
- 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the AdultCanadian Journal of Cardiology, 2013
- Normocalcemic Primary HyperparathyroidismJournal of Clinical Densitometry, 2013
- Association of Intact Parathyroid Hormone Levels with Subsequent Hip BMD Loss: The Osteoporotic Fractures in Men (MrOS) StudyJournal of Clinical Endocrinology & Metabolism, 2012
- Serum Leptin, Parathyroid Hormone, 1,25-Dihydroxyvitamin D, Fibroblast Growth Factor 23, Bone Alkaline Phosphatase, and Sclerostin Relationships in ObesityJournal of Clinical Endocrinology & Metabolism, 2012
- Leptin administration does not prevent the bone mineral metabolism changes induced by weight lossMetabolism, 2011
- Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly IndividualsArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1α,25-dihydroxyvitamin D3 synthesis in leptin-deficient ob/ob MiceJournal of Bone and Mineral Research, 2010
- Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screeningActa Endocrinologica, 2006
- Fat mass is an important predictor of parathyroid hormone levels in postmenopausal womenBone, 2006
- Long‐term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertensionWorld Journal of Surgery, 1992